{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2965"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2965","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"CHEMICAL SYNTHESIS AND BIOLOGICAL APPLICATION OF SENSITIVE RNA","abstract":"In the field of epigenetics - the dynamic collection of chemical modifications that overlay DNA/RNA - there is increasing interest in the potential for therapeutic and research-based utilization of the epitranscriptomics: those epigenetic modifications specific to RNA. Epitranscriptomics can give us a new approach to understanding and treating RNA viruses, like SARS-CoV-2. Given viruses are often found modified by human epitranscriptomic machinery, understanding how these modifications can modulate virulence is of high interest. We have shown that the N1-methyladensoine modification causes RNA synthesis termination in the SARS-CoV-2 replication complex, and thus may explain the differences in symptoms observed in individuals. Furthermore, we proved that this modification can be incorporated into RNA via its triphosphate form using the same replication complex, and thus could serve as an effective natural antiviral therapeutic to SARS-CoV-2 and other coronaviruses. Sensitive epitranscriptomic modifications (e.g., ac4C) are yet another category of epigenetics which are similarly of high interest to biological research. However, the chemical synthesis of RNA containing sensitive epitranscriptomic modifications is extremely limited. The standard synthesis, cleavage and deprotection, methods currently used cannot synthesize RNA with sensitive groups. This is chiefly due to the harsh basic conditions needed to deprotect and cleave the RNA, following synthesis. Attempts at creating new protecting groups and solid support linkers have made some progress in the synthesis of sensitive RNA, but their methods cannot produce RNA of acceptable length or purity due to lowered coupling yields and cumbersome photocleavage steps. We have developed a novel silyl containing cyclizable protecting group (SoM) and linker (SoA) that have achieved RNA synthesis at the length of 26 nucleotides that retained the sensitive modification ac4C in good purity and yields.","abstract_html":"In the field of epigenetics - the dynamic collection of chemical modifications that overlay DNA/RNA - there is increasing interest in the potential for therapeutic and research-based utilization of the epitranscriptomics: those epigenetic modifications specific to RNA. Epitranscriptomics can give us a new approach to understanding and treating RNA viruses, like SARS-CoV-2. Given viruses are often found modified by human epitranscriptomic machinery, understanding how these modifications can modulate virulence is of high interest. We have shown that the N1-methyladensoine modification causes RNA synthesis termination in the SARS-CoV-2 replication complex, and thus may explain the differences in symptoms observed in individuals. Furthermore, we proved that this modification can be incorporated into RNA via its triphosphate form using the same replication complex, and thus could serve as an effective natural antiviral therapeutic to SARS-CoV-2 and other coronaviruses. Sensitive epitranscriptomic modifications (e.g., ac4C) are yet another category of epigenetics which are similarly of high interest to biological research. However, the chemical synthesis of RNA containing sensitive epitranscriptomic modifications is extremely limited. The standard synthesis, cleavage and deprotection, methods currently used cannot synthesize RNA with sensitive groups. This is chiefly due to the harsh basic conditions needed to deprotect and cleave the RNA, following synthesis. Attempts at creating new protecting groups and solid support linkers have made some progress in the synthesis of sensitive RNA, but their methods cannot produce RNA of acceptable length or purity due to lowered coupling yields and cumbersome photocleavage steps. We have developed a novel silyl containing cyclizable protecting group (SoM) and linker (SoA) that have achieved RNA synthesis at the length of 26 nucleotides that retained the sensitive modification ac4C in good purity and yields.","abstract_has_math":false,"creators":["Apostle, Alexander T."],"institution":null,"degree_name":"Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)","degree_level":"Open Access Dissertation","degree_discipline":"Department of Chemistry","degree_department":null,"school":null,"contributors":["Shiyue Fang","Yinan Yuan"],"advisors":[],"committee_chairs":[],"committee_members":["Marina Tanasova","Xiaohu (Mark) Tang","Tarun Dam"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:19:12Z","subjects":["novel protecting group","RNA chemical synthesis","sensitive epitranscriptomic modification","Molecular Biology","Nucleic Acids, Nucleotides, and Nucleosides","Organic Chemistry"],"languages":[],"rights":[],"rights_urls":["http://creativecommons.org/licenses/by/4.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/1849"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/1849","href":"https://digitalcommons.mtu.edu/etdr/1849","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/1849","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/1849","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2965","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Shiyue Fang","Yinan Yuan"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Marina Tanasova","Xiaohu (Mark) Tang","Tarun Dam"]},{"key":"dc:creator","label":"Author","values":["Apostle, Alexander T."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2024-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["novel protecting group","RNA chemical synthesis","sensitive epitranscriptomic modification","Molecular Biology","Nucleic Acids, Nucleotides, and Nucleosides","Organic Chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.license","label":"Dc Rights License","values":["http://creativecommons.org/licenses/by/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/1849","https://digitalcommons.mtu.edu/etdr/1849"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In the field of epigenetics - the dynamic collection of chemical modifications that overlay DNA/RNA - there is increasing interest in the potential for therapeutic and research-based utilization of the epitranscriptomics: those epigenetic modifications specific to RNA. Epitranscriptomics can give us a new approach to understanding and treating RNA viruses, like SARS-CoV-2. Given viruses are often found modified by human epitranscriptomic machinery, understanding how these modifications can modulate virulence is of high interest. We have shown that the N1-methyladensoine modification causes RNA synthesis termination in the SARS-CoV-2 replication complex, and thus may explain the differences in symptoms observed in individuals. Furthermore, we proved that this modification can be incorporated into RNA via its triphosphate form using the same replication complex, and thus could serve as an effective natural antiviral therapeutic to SARS-CoV-2 and other coronaviruses. Sensitive epitranscriptomic modifications (e.g., ac4C) are yet another category of epigenetics which are similarly of high interest to biological research. However, the chemical synthesis of RNA containing sensitive epitranscriptomic modifications is extremely limited. The standard synthesis, cleavage and deprotection, methods currently used cannot synthesize RNA with sensitive groups. This is chiefly due to the harsh basic conditions needed to deprotect and cleave the RNA, following synthesis. Attempts at creating new protecting groups and solid support linkers have made some progress in the synthesis of sensitive RNA, but their methods cannot produce RNA of acceptable length or purity due to lowered coupling yields and cumbersome photocleavage steps. We have developed a novel silyl containing cyclizable protecting group (SoM) and linker (SoA) that have achieved RNA synthesis at the length of 26 nucleotides that retained the sensitive modification ac4C in good purity and yields."]},{"key":"dc:title","label":"Title","values":["CHEMICAL SYNTHESIS AND BIOLOGICAL APPLICATION OF SENSITIVE RNA"]}]}],"canonical_facts":{"dc:contributor":["Shiyue Fang","Yinan Yuan"],"dc:contributor.committeemember":["Marina Tanasova","Xiaohu (Mark) Tang","Tarun Dam"],"dc:creator":["Apostle, Alexander T."],"dc:date.created":["2024-01-01T08:00:00Z"],"dc:description.abstract":["In the field of epigenetics - the dynamic collection of chemical modifications that overlay DNA/RNA - there is increasing interest in the potential for therapeutic and research-based utilization of the epitranscriptomics: those epigenetic modifications specific to RNA. Epitranscriptomics can give us a new approach to understanding and treating RNA viruses, like SARS-CoV-2. Given viruses are often found modified by human epitranscriptomic machinery, understanding how these modifications can modulate virulence is of high interest. We have shown that the N1-methyladensoine modification causes RNA synthesis termination in the SARS-CoV-2 replication complex, and thus may explain the differences in symptoms observed in individuals. Furthermore, we proved that this modification can be incorporated into RNA via its triphosphate form using the same replication complex, and thus could serve as an effective natural antiviral therapeutic to SARS-CoV-2 and other coronaviruses. Sensitive epitranscriptomic modifications (e.g., ac4C) are yet another category of epigenetics which are similarly of high interest to biological research. However, the chemical synthesis of RNA containing sensitive epitranscriptomic modifications is extremely limited. The standard synthesis, cleavage and deprotection, methods currently used cannot synthesize RNA with sensitive groups. This is chiefly due to the harsh basic conditions needed to deprotect and cleave the RNA, following synthesis. Attempts at creating new protecting groups and solid support linkers have made some progress in the synthesis of sensitive RNA, but their methods cannot produce RNA of acceptable length or purity due to lowered coupling yields and cumbersome photocleavage steps. We have developed a novel silyl containing cyclizable protecting group (SoM) and linker (SoA) that have achieved RNA synthesis at the length of 26 nucleotides that retained the sensitive modification ac4C in good purity and yields."],"dc:identifier":["10.37099/mtu.dc.etdr/1849","https://digitalcommons.mtu.edu/etdr/1849"],"dc:rights.license":["http://creativecommons.org/licenses/by/4.0/"],"dc:subject":["novel protecting group","RNA chemical synthesis","sensitive epitranscriptomic modification","Molecular Biology","Nucleic Acids, Nucleotides, and Nucleosides","Organic Chemistry"],"dc:title":["CHEMICAL SYNTHESIS AND BIOLOGICAL APPLICATION OF SENSITIVE RNA"],"thesis:degree_discipline":["Department of Chemistry"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)"]},"updated_at":"2026-11-19T08:19:12Z"}